Zoetis, the animal health unit of pharmaceutical giant Pfizer, plans to stop making Panolog, a popular ear-and-skin medication for pets.
“We have made the decision to discontinue production of our Panolog ointment and cream products,” Zoetis spokesman Deron Johnson told Examiner.com in a two-sentence statement Feb. 25. “This decision is based on a regular review of our product portfolio and consideration of future API (active pharmaceutical ingredient) supplies; it is not related to the quality or integrity of the finished product currently available on the market.”
More details about the prescription drug’s demise were not immediately available from Zoetis.
“Panolog treats a variety of inflammatory ear infections and skin infections caused by susceptible bacteria and yeast,” says Drs. Foster and Smith, one of several online pharmacies that sell the product. “Contains antibiotic, anti-inflammatory, anti-itch and antifungal medications. Ointment is simple to apply to ears or skin.”
Animax, a generic version of Panolog, is made by Dechra and will remain on the market, a company spokeswoman told Examiner.com Feb. 27.
“Animax Ointment and Panalog contain the same active ingredients,” said veterinarian Nancy Zimmerman, director of U.S. marketing at Dechra Veterinary Products. “We have no plans at this time to discontinue production of Animax. Both Animax and Panalog are prescription veterinary medications, so if [pet owners] are looking for alternatives to Panalog, I recommend they talk to their veterinarian to get the best advice.”